Max Robotics — Global Service Robot Directory + US Certification

About

Chenglei Gu is a leading researcher in gynecologic oncology, with a focus on advancing surgical techniques and preclinical models for gynecological tumors. Dr. Gu’s most cited work established the patient-derived tumor xenograft (PDTX) model for gynecological cancers, a critical tool for personalized medicine that has garnered 16 citations. This foundational contribution enables more accurate drug testing and tumor biology studies. Dr. Gu has also made significant strides in comparing survival outcomes across surgical approaches for early-stage cervical cancer, including abdominal, laparoscopic, robot-assisted, and vaginal radical hysterectomy—a study with 6 citations that informs clinical decision-making. Notably, Dr. Gu’s research on robotic hysterectomy for large uteri (over 1000 g) addresses a high-risk surgical challenge, with recent findings from a high-volume center. Additional work includes robotic cesarean scar pregnancy resection and hysterotomy repair, showcasing technical innovation. With a cumulative impact of over 30 citations, Dr. Gu’s contributions bridge preclinical modeling and advanced surgical oncology, offering valuable insights for both researchers and clinicians aiming to improve outcomes in gynecologic cancer care.